nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.08.2012 | Maternal-Fetal Medicine

Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome

verfasst von: Bilge Cetinkaya Demir, Kemal Ozerkan, Sevda Erer Ozbek, Nalan Yıldırım Eryılmaz, Gokhan Ocakoglu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate and compare the effectiveness of magnesium sulfate (MgSO₄) and mannitol in the treatment of posterior reversible encephalopathy syndrome (PRES) in eclamptic women.

Study design

This retrospective analysis includes 62 eclamptic women between 22 and 40 weeks of gestation who were diagnosed with PRES in a tertiary care center. To treat neurological symptoms, 34 women received magnesium sulfate (Group 1) and the remaining 28 received 20% mannitol (Group 2) at the discretion of treating physician.

Results

Ten patients from both Group 1 (29%) and Group 2 (35.7%) were normotensive at admission. 59 of 62 patients presented with seizure. All patients underwent fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). Parietooccipital region and cerebellum were the most commonly affected areas. The duration of treatment was significantly shorter in Group 1 than Group 2 (p < 0.001). Neurological examinations and the recovery after treatment were significantly better in favor of MgSO₄ group (p = 0.039).

Conclusion

Mannitol is not superior to magnesium sulfate in achieving neurological recovery. Magnesium sulfate seems to be the agent of choice for treatment of PRES.

Sibai BM, Eclampsia VI (1990) Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049–1055PubMed

Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BH (2002) Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 186:1174–1177PubMedCrossRef

Easton DJ (1998) Severe preeclampsia/eclampsia hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 8:53–58PubMedCrossRef

Guyton AC (2006) Cerebral blood flow, cerebrospinal fluid and brain metabolism. In: Gutyton AC (ed) Textbook of medical physiology, 11th edn. Elsevier Saunders, Philadelphia, pp 761–768

Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B et al (1992) Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 159:379–383PubMed

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef

Servillo G, Striano P, Striano S, Tortora F, De Robertis E, Rossano F et al (2003) Posterior reversible encephalopathy syndrome (PRES) in obstetric critically ill patients. Intensive Care Med 29:2323–2326PubMedCrossRef

Antunes NL, Small TN, George D, Boulad F, Lis E (1999) Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 20:241–243PubMedCrossRef

Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 11:136–144PubMedCrossRef

10.

Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21:1199–1206PubMed

11.

Loureiro R, Leite CC, Kahhale S, Freire S, Sousa B, Cardoso EF et al (2003) Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol 189:1350–1355PubMedCrossRef

12.

Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049PubMedCrossRef

13.

Mckinney AM, Short J, Truwit LC, Mckinney ZJ, Kozak OS, SantaCruz KS et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Radiol 189:904–912

14.

Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D (2009) Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51:373–383PubMedCrossRef

15.

Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432PubMedCrossRef

16.

Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG (2009) Brain lesions several years after eclampsia. Am J Obstet Gynecol 200(5):504 (e1–e5)PubMedCrossRef

17.

Mattar F, Sibai BM (2000) Eclampsia. VIII. Risk factors of maternal morbidity. Am J Obstet Gynecol 182:307–312PubMedCrossRef

18.

Cipolla MJ (2007) Cerebrovascular function in pregnancy and eclampsia. Hypertension 50:14–24PubMedCrossRef

19.

Narbone MC, Musolino R, Granata F, Mazzù I (2006) PRES: posterior or potentially reversible encephalopathy syndrome? Neurol Sci 27:187–189PubMedCrossRef

20.

The Magpie Trial Collaborative Group (2002) Do women with pre-eclampsia, and their babes, benefit from magnesium sulfate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359:1877–1890CrossRef

21.

Euser AG, Cipolla MJ (2009) Magnesium sulfate for the treatment of eclampsia. Stroke 40:1169–1175PubMedCrossRef

22.

Pollay M (1996) Blood–brain barrier, cerebral edema. In: Wilkins RH, Rengachary SS (eds) Neurosurgery, 2nd edn. Mc Graw Hill Book Co., NewYork, pp 335–344

23.

Donato T, Shapira Y, Artru A, Powers K (1994) Effect of mannitol on cerebrospinal fluid dynamics and brain tissue edema. Anesth Analg 78:58–66PubMedCrossRef

Titel: Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome
verfasst von: Bilge Cetinkaya Demir
Kemal Ozerkan
Sevda Erer Ozbek
Nalan Yıldırım Eryılmaz
Gokhan Ocakoglu
Publikationsdatum: 01.08.2012
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 2/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2268-8

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome

Abstract

Objective

Study design

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objective

Study design

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2012

Changes in endometrial receptivity in women with Asherman’s syndrome undergoing hysteroscopic adhesiolysis

Obstetricians’ perspective towards cesarean section delivery based on professional level: experience from Egypt

Effect of AT1R knockdown on ishikawa cell proliferation induced by estrogen

Risk factors for neonatal brachial plexus paralysis

Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH)

Does obesity complicate perioperative course in patients undergoing abdominal hysterectomy?

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie